CG HOLDING CO.

Profile

Company Names

CG HOLDING CO.

Addresses

117 E. LOUISA STREET, #561, SEATTLE, WA 98102

Phone Numbers

206-701-5840

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2022

State Incorporated:

DELAWARE

Total Amount Raised:

$10,997.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2022-04-05 
$10,997.00 
$10,997.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
TOM 
 
FRINZI 
DIRECTOR
EYEBRAIN MEDICAL, INC.   |  AURION BIOTECH, INC.   |  CG HOLDING CO.   |  VIALASE, INC.
JOHN 
 
GEBHART 
DIRECTOR
VENTRIPOINT DIAGNOSTICS LTD   |  QLIANCE MEDICAL MANAGEMENT INC.   |  CG HOLDING CO.
BERNARDINO 
 
ILIAKIS 
EXECUTIVE OFFICER, DIRECTOR
CG HOLDING CO.
PATRICK 
 
LALLY 
DIRECTOR
BREAZY INC.   |  AURION BIOTECH, INC.   |  CG HOLDING CO.
RICHARD 
 
LINDSTROM 
DIRECTOR
VERTICAL HEALTH SOLUTIONS INC   |  OCULAR THERAPEUTIX, INC   |  FORSIGHT VISION6, INC.   |  ENCORE VISION, INC.   |  ALPHAEON CORP   |  TEARLAB CORP   |  POGOTEC, INC.   |  IMPRIMIS PHARMACEUTICALS, INC.   |  SIGHTLIFE SURGICAL, INC.   |  UNITED VISION PARTNERS HOLDINGS, LLC   |  EQUINOX, INC.   |  IANTECH, INC.   |  CORNEAGEN INC.   |  EQUINOX OPHTHALMIC, INC.   |  THEROPTIX, INC.   |  LENTECHS LLC   |  SURFACE OPHTHALMICS, INC.   |  SYDNEXIS, INC.   |  CG HOLDING CO.   |  IOR HOLDINGS, INC.   |  VINCI PHARMACEUTICALS, INC.
ANNIE 
 
THOMPSON 
EXECUTIVE OFFICER
CG HOLDING CO.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-04-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-04-05 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#